Iopromide is an X-ray contrast agent used during various types of imaging tests such as angiography and contrast computed tomography (CT) imaging tests. It functions as a contrast agent by opacifying blood vessels in the flow path of the contrast agent, permitting radiographic visualization of the internal structures until significant hemodilution occurs.
- Mechanism
- Curator reviewed · 1 reference
Iopromide is a nonionic iodinated, water-soluble, radiographic contrast medium that is available in two stable, ready-to-use solutions of different concentrations (i.e., 300 mg I/mL and 370 mg I/mL). Following intravascular injection, iopromide provides radiographic opacification of the vasculature and extracellular space in the path of flow of the agent, allowing diagnostic assessment of the limbs and internal organs until significant dilution occurs.
- Primary indication
- Iopromide, as the product IOVIST, is approved by the FDA for use as an intra-arterial or intravenous X-ray contrast agent.Curator reviewed · 42 structured indications
- Formula / weight
- C18H24I3N3O8 · 791.1119 g/mol (avg)
- First approval
- Canada, 2007 · United States, 2006
- Code names
- ZK-35760
- Brand names
Resolves to
DGAIEPBNLOQYER-UHFFFAOYSA-NSMILESCOCC(=O)NC1=C(I)C(C(=O)N(C)CC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1IWhat you can answer from here — as of July 03, 2026
Which drugs share a target with Iopromide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account